Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reykjavik Political Voice.
Funding Partner Spotlight
UN Environmental Program
·
May 9, 2025
Courtesty of Denmark Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) are key contributors to UNEP's Environment Fund, and their strong partnership with UNEP highlights their shared commitment to addressing the triple planetary...
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire, Inc.
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11,...
Oculis Reports Q1 2025 Financial Results and Provides Company Update
GlobeNewswire, Inc.
·
May 8, 2025
The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor’s (OCS-05)...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Oculis to Present at Upcoming May Investor Conferences
GlobeNewswire, Inc.
·
May 7, 2025
ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The...
Costco Wholesale Corporation Reports May Sales Results
GlobeNewswire, Inc.
·
June 4, 2025
ISSAQUAH, Wash., June 04, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today reported net sales of $20.97 billion for the retail month of May, the four weeks ended June 1, 2025, an increase of...
NATO’s Rutte Calls for Major Defense Budgets Boost
MENAFN
·
June 2, 2025
(MENAFN) NATO Secretary General Mark Rutte declared on Monday that alliance members must sharply increase defense budgets well beyond the current 2% of GDP guideline, warning that emerging threats from Russia, China, and North Korea demand far...
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
GlobeNewswire, Inc.
·
May 1, 2025
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
Amaroq presents Nalunaq 2024 Exploration Results
GlobeNewswire, Inc.
·
February 27, 2025
Reykjavík, Feb. 27, 2025 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company” or the “Corporation”) Amaroq presents Nalunaq 2024 Exploration Results ** Highly Encouraging Underground Exploration Results and Continued Expansion of Key Mineralized Veins...
Comprehensive Guide to Leading Bitcoin Mining Platforms: Top 7 Best Cryptocurrency Cloud Mining Platforms to Make Money in 2025
GlobeNewswire, Inc.
·
May 28, 2025
Wilmington, Delaware, May 28, 2025 (GLOBE NEWSWIRE) -- In 2025, Bitcoin, Litecoin, and Dogecoin continue to dominate the crypto mining scene. These three coins remain top choices for investors due to their strong market capitalization, consistent...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
UK Reveals Cutting-Edge AI-Powered Arctic Surveillance Initiative
MENAFN
·
May 27, 2025
(MENAFN) The United Kingdom on Tuesday revealed a cutting-edge artificial intelligence initiative aimed at enhancing surveillance across the Arctic and identifying potential threats from hostile nations. According to a statement from the Foreign...
Norway, Poland Formalize New Agreement
MENAFN
·
April 23, 2025
(MENAFN) Norway and Poland have formalized a new agreement on Wednesday under the European Economic Area (EEA) and Norway Grants to promote economic and social progress in Poland while strengthening bilateral ties, according to a press release...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
March 18, 2025
HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...
Awards under Restricted Share Unit Plan
GlobeNewswire, Inc.
·
February 12, 2025
Reykjavík, Feb. 12, 2025 (GLOBE NEWSWIRE) -- ("Amaroq" or the "Company") Awards under Restricted Share Unit Plan (the “RSU”) TORONTO, ONTARIO – 12 February 2025 – Amaroq Minerals Ltd. (AIM, TSX-V, NASDAQ Iceland: AMRQ), an independent mining...
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
GlobeNewswire, Inc.
·
April 15, 2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Costco Wholesale Corporation Reports Third Quarter and Year-To-Date Operating Results for Fiscal 2025
GlobeNewswire, Inc.
·
May 29, 2025
ISSAQUAH, Wash., May 29, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced its operating results for the third quarter (twelve weeks) and the first 36 weeks of fiscal 2025, ended May...
Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt
GlobeNewswire, Inc.
·
March 10, 2025
REYKJAVIK, Iceland and MORRISTOWN, N.J., March 10, 2025 (GLOBE NEWSWIRE) -- Alvogen Pharma US, Inc. (“Alvogen” or the “Company”), a privately owned US-based pharmaceutical company, has completed a comprehensive refinancing of its capital...
Russia’s Looming Threat in Northern Europe
The Arctic Institute
·
April 17, 2025
Back to Publications Russian President Vladimir Putin chairs a video-conference meeting on the development of the Arctic zone of the Russian Federation, 13th April 2022. Photo: President of Russia Northern Europe has historically been an area of...